Genomic Health (GHDX) Tops Q1 EPS by 11c
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Financial Fact:
Research and development: 46.4M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 46.4M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Genomic Health (NASDAQ: GHDX) reported Q1 EPS of ($0.11), $0.11 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $92.6 million versus the consensus estimate of $88.96 million.
For earnings history and earnings-related data on Genomic Health (GHDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
